首页 > 最新文献

Cardiovascular & hematological agents in medicinal chemistry最新文献

英文 中文
Genetic Underpinnings of Pulmonary Fibrosis: An Overview. 肺纤维化的遗传基础:概述。
Pub Date : 2024-01-01 DOI: 10.2174/0118715257261006231207113809
Sushweta Mahalanobish, Sumit Ghosh, Parames C Sil

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disorder, in which genetic and environmental factors are involved in disease onset. Although, by definition, the disease is considered idiopathic in nature, evidence-based studies have indicated familial cases of pulmonary fibrosis, in which genetic factors contribute to IPF pathogenesis.

Methods: Both common as well as rare genetic variants are associated with sporadic as well as familial forms of IPF. Although clinical inferences of the genetic association have still not been explored properly, observation-based studies have found a genotypic influence on disease development and outcome.

Results: Based on genetic studies, individuals with a risk of IPF can be easily identified and can be classified more precisely. Identification of genetic variants also helps to develop more effective therapeutic approaches.

Conclusion: Further comprehensive research is needed to get a blueprint of IPF pathogenesis. The rapidly evolving field of genetic engineering and molecular biology, along with the bioinformatics approach, will possibly explore a new horizon very soon to achieve this goal.

简介特发性肺纤维化(IPF)是一种慢性进行性疾病,发病与遗传和环境因素有关。虽然根据定义,该病属于特发性疾病,但循证研究表明,在家族性肺纤维化病例中,遗传因素是导致 IPF 发病的原因之一:方法:常见和罕见的遗传变异均与散发性和家族性 IPF 有关。方法:常见和罕见的遗传变异均与散发性和家族性 IPF 有关。虽然遗传关联的临床推论尚未得到充分探讨,但基于观察的研究发现,基因型对疾病的发展和预后有影响:结果:基于基因研究,可以很容易地识别出有患 IPF 风险的个体,并对其进行更精确的分类。鉴定基因变异也有助于开发更有效的治疗方法:要获得 IPF 发病机制的蓝图,还需要进一步的综合研究。快速发展的基因工程和分子生物学领域,以及生物信息学方法,可能很快就会为实现这一目标开拓出一片新天地。
{"title":"Genetic Underpinnings of Pulmonary Fibrosis: An Overview.","authors":"Sushweta Mahalanobish, Sumit Ghosh, Parames C Sil","doi":"10.2174/0118715257261006231207113809","DOIUrl":"10.2174/0118715257261006231207113809","url":null,"abstract":"<p><strong>Introduction: </strong>Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disorder, in which genetic and environmental factors are involved in disease onset. Although, by definition, the disease is considered idiopathic in nature, evidence-based studies have indicated familial cases of pulmonary fibrosis, in which genetic factors contribute to IPF pathogenesis.</p><p><strong>Methods: </strong>Both common as well as rare genetic variants are associated with sporadic as well as familial forms of IPF. Although clinical inferences of the genetic association have still not been explored properly, observation-based studies have found a genotypic influence on disease development and outcome.</p><p><strong>Results: </strong>Based on genetic studies, individuals with a risk of IPF can be easily identified and can be classified more precisely. Identification of genetic variants also helps to develop more effective therapeutic approaches.</p><p><strong>Conclusion: </strong>Further comprehensive research is needed to get a blueprint of IPF pathogenesis. The rapidly evolving field of genetic engineering and molecular biology, along with the bioinformatics approach, will possibly explore a new horizon very soon to achieve this goal.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"367-374"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green Synthesis of Silver Nanoparticles using Coriandrum sativum and Murraya koenigii Leaf Extract and its Thrombolytic Activity. 利用芫荽和鹅掌楸叶提取物绿色合成银纳米粒子及其溶栓活性
Pub Date : 2024-01-01 DOI: 10.2174/0118715257279159240118050207
Priyanca Pram, Nikita Mishra, Mohanasrinivasan Vaithilingam, Merlyn Keziah Samuel, Maneesha Mohanan, Neeti Kothari, Subathra Devi Chandrasekaran

Background: Plants have been used for ages in traditional medicine, and it is exciting to perceive how recent research has recognized the bioactive compounds liable for their beneficial effects. Green synthesis of metal nanoparticles is a hastily emergent research area in nanotechnology. This study describes the synthesis of silver nanoparticles (AgNPs) using Coriandrum sativum and Murraya koenigii leaf extract and its thrombolytic activity.

Objective: The aim of the study was to determine the clot lysis activity of Coriandrum sativum and Murraya koenigii synthesized silver nanoparticles.

Methods: Leaves of Coriandrum sativum and Murraya koenigii were collected. Methanolic extraction of the plant sample was done through a Soxhlet extractor. The methanolic extract obtained from both the leaves was subjected to GC-MS analysis. The synthesized NPs from leaf extracts were monitored for analysis, where the typical X-ray diffraction pattern and its diffraction peaks were identified. 3D image of the NPs was analysed by Atomic Force Microscopy. The surface charge of nanoparticles was identified by Zeta potential. The Clot lysis activity of Coriandrum sativum and Murraya koenigii synthesized silver nanoparticles were analysed by the modified Holmstorm method.

Results: The thrombolytic property of the methanolic extract of plants Coriandrum sativum showed clot lysis activity at 2.5 mg/mL with 45.99% activity, and Murraya koenigii extract with 66.56% activity. The nanoparticles (Nps) from Coriandrum sativum showed clot lysis activity at 2.5 mg/mL with 58.29% activity, and NPs from Murraya koenigii with 54.04% activity. Coriandrum sativum in GC-MS exhibited 3 peaks, whereas Murraya koenigii extract showed five peaks with notable bioactive compounds.

Conclusion: These NPs were further used for biomedical applications after being fixed by an organic encapsulation agent. The present research reveals the usefulness of Coriandrum sativum and Murraya koenigii for the environmentally friendly manufacture of silver nanoparticles.

背景:植物在传统医学中的应用由来已久,令人兴奋的是,近年来的研究已经认识到了植物中具有生物活性的化合物对人体的益处。金属纳米粒子的绿色合成是纳米技术中一个新兴的研究领域。本研究介绍了利用芫荽和鹅掌楸叶提取物合成银纳米粒子(AgNPs)及其溶栓活性:本研究旨在确定芫荽和墨旱莲合成的银纳米粒子的血栓溶解活性:方法:采集芫荽和墨旱莲的叶子。通过索氏提取器对植物样本进行甲醇提取。对从这两种叶子中提取的甲醇提取物进行气相色谱-质谱分析。对从叶片提取物中合成的 NPs 进行了监测分析,确定了典型的 X 射线衍射图样及其衍射峰。原子力显微镜分析了 NPs 的三维图像。通过 Zeta 电位确定了纳米粒子的表面电荷。用改进的 Holmstorm 法分析了芫荽和鹅掌楸合成的银纳米粒子的溶栓活性:结果:植物芫荽的甲醇提取物在 2.5 毫克/毫升的溶栓活性为 45.99%,而 Murraya koenigii 提取物的溶栓活性为 66.56%。从芫荽中提取的纳米粒子(Nps)在 2.5 毫克/毫升的浓度下具有 58.29% 的凝块溶解活性,而从墨旱莲中提取的纳米粒子则具有 54.04% 的活性。在气相色谱-质谱(GC-MS)中,芫荽显示出 3 个峰值,而九里香提取物则显示出 5 个峰值,其中含有显著的生物活性化合物:这些 NPs 经有机封装剂固定后可进一步用于生物医学应用。本研究揭示了芫荽和九里香在以环境友好型方式制造银纳米粒子方面的用途。
{"title":"Green Synthesis of Silver Nanoparticles using <i>Coriandrum sativum</i> and <i>Murraya koenigii</i> Leaf Extract and its Thrombolytic Activity.","authors":"Priyanca Pram, Nikita Mishra, Mohanasrinivasan Vaithilingam, Merlyn Keziah Samuel, Maneesha Mohanan, Neeti Kothari, Subathra Devi Chandrasekaran","doi":"10.2174/0118715257279159240118050207","DOIUrl":"https://doi.org/10.2174/0118715257279159240118050207","url":null,"abstract":"<p><strong>Background: </strong>Plants have been used for ages in traditional medicine, and it is exciting to perceive how recent research has recognized the bioactive compounds liable for their beneficial effects. Green synthesis of metal nanoparticles is a hastily emergent research area in nanotechnology. This study describes the synthesis of silver nanoparticles (AgNPs) using <i>Coriandrum sativum</i> and <i>Murraya koenigii</i> leaf extract and its thrombolytic activity.</p><p><strong>Objective: </strong>The aim of the study was to determine the clot lysis activity of <i>Coriandrum sativum</i> and <i>Murraya koenigii</i> synthesized silver nanoparticles.</p><p><strong>Methods: </strong>Leaves of <i>Coriandrum sativum</i> and <i>Murraya koenigii</i> were collected. Methanolic extraction of the plant sample was done through a Soxhlet extractor. The methanolic extract obtained from both the leaves was subjected to GC-MS analysis. The synthesized NPs from leaf extracts were monitored for analysis, where the typical X-ray diffraction pattern and its diffraction peaks were identified. 3D image of the NPs was analysed by Atomic Force Microscopy. The surface charge of nanoparticles was identified by Zeta potential. The Clot lysis activity of <i>Coriandrum sativum</i> and <i>Murraya koenigi</i>i synthesized silver nanoparticles were analysed by the modified Holmstorm method.</p><p><strong>Results: </strong>The thrombolytic property of the methanolic extract of plants <i>Coriandrum sativum</i> showed clot lysis activity at 2.5 mg/mL with 45.99% activity, and <i>Murraya koenigii</i> extract with 66.56% activity. The nanoparticles (Nps) from <i>Coriandrum sativum</i> showed clot lysis activity at 2.5 mg/mL with 58.29% activity, and NPs from <i>Murraya koenigii</i> with 54.04% activity. <i>Coriandrum sativum</i> in GC-MS exhibited 3 peaks, whereas <i>Murraya koenigii</i> extract showed five peaks with notable bioactive compounds.</p><p><strong>Conclusion: </strong>These NPs were further used for biomedical applications after being fixed by an organic encapsulation agent. The present research reveals the usefulness of <i>Coriandrum sativum</i> and <i>Murraya koenigii</i> for the environmentally friendly manufacture of silver nanoparticles.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":"22 2","pages":"230-239"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for Therapy. 靶向糖尿病心肌病关键分子通路的 MicroRNAs 正在成为有价值的疗法。
Pub Date : 2024-01-01 DOI: 10.2174/0118715257265947231129074526
Priyanka Mathur, Sharad Saxena, Bhawna Saxena, Vibha Rani

MicroRNAs have emerged as an important regulator of post-transcriptional gene expression studied extensively in many cancers, fetal development, and cardiovascular diseases. Their endogenous nature and easy manipulation have made them potential diagnostic and therapeutic molecules. Diseases with complex pathophysiology such as Diabetic Cardiomyopathy display symptoms at a late stage when the risk of heart failure has become very high. Therefore, the utilization of microRNAs as a tool to study pathophysiology and device-sustainable treatments for DCM could be considered. The present review focuses on the mechanistic insights of diabetic cardiomyopathy and the potential role of microRNAs.

MicroRNA 是转录后基因表达的重要调节因子,在许多癌症、胎儿发育和心血管疾病中被广泛研究。它们的内源性和易操作性使其成为潜在的诊断和治疗分子。糖尿病心肌病等病理生理学复杂的疾病在晚期才出现症状,此时心力衰竭的风险已非常高。因此,可以考虑利用 microRNA 作为研究病理生理学和 DCM 设备可持续治疗的工具。本综述的重点是糖尿病心肌病的机理研究以及 microRNAs 的潜在作用。
{"title":"MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for Therapy.","authors":"Priyanka Mathur, Sharad Saxena, Bhawna Saxena, Vibha Rani","doi":"10.2174/0118715257265947231129074526","DOIUrl":"10.2174/0118715257265947231129074526","url":null,"abstract":"<p><p>MicroRNAs have emerged as an important regulator of post-transcriptional gene expression studied extensively in many cancers, fetal development, and cardiovascular diseases. Their endogenous nature and easy manipulation have made them potential diagnostic and therapeutic molecules. Diseases with complex pathophysiology such as Diabetic Cardiomyopathy display symptoms at a late stage when the risk of heart failure has become very high. Therefore, the utilization of microRNAs as a tool to study pathophysiology and device-sustainable treatments for DCM could be considered. The present review focuses on the mechanistic insights of diabetic cardiomyopathy and the potential role of microRNAs.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"298-307"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Quercetin's Bioenhancing Effect on Oral Pharmacokinetics of Rosuvastatin in Wistar Rats Using RP-HPLC Method. 采用 RP-HPLC 法评估槲皮素对瑞舒伐他汀在 Wistar 大鼠中口服药代动力学的生物增强效应
Pub Date : 2024-01-01 DOI: 10.2174/0118715257258735231016112348
Rachana S Bhimanwar, Lata P Kothapalli, Akshay Khawshi

Background: The absolute oral bioavailability of rosuvastatin (RST), a secondgeneration statin, is low i.e. 20% and only 10% is recovered as metabolite N-desmethy l rosuvistatin. Since it is a hydrophilic statin, RST relies on the organic anion transporting polypeptide- 1B1 (OATP-1B1), as the key mechanism for active transport into hepatocytes. Quercetin (QUE) being a bio enhancer and inhibitor of OATP1B1 can augment the bioavailability and pharmacokinetics of RST.

Objectives: The present study includes the development of a simple and validated bioanalytical Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the estimation of RST and to study the effect of co-administration of QUE as a bio enhancer on its bioavailability.

Methods: An analytical column of Kromasil 100, C18 (250 mm × 4.6 mm, 5 μm), was used for chromatographic separationand acetonitrile (ACN): acetic acid buffer pH 3.0 adjusted with glacial acetic acid (55:45 Vol. %) as mobile phase with flow rate 1.0 ml/min monitored at 242 nm. The ACN: methanol (50:50 Vol. %) was employed as the final solvent for extraction. The developed method has been successfully applied in a study on the pharmacokinetics of the drug RST in rats after co-administration of QUE, which was carried out using non-compartmental analysis in order to estimate the blood concentration of the drug.

Results: The pharmacokinetics of RST was found to be altered significantly (highest concentration of RST in the blood (Cmax) = 67.3 ng/ml to 122.2 ng/ml) (p < 0.001), area under curve (AUC)0-t (p < 0.0001) and AUC0-inf (p = 0.0005) when co-administered with QUE at 120 min (tmax).

Conclusion: The results are in accordance with the fact that QUE increases plasma levels in rats through herb-drug interactions.

背景:第二代他汀类药物罗伐他汀(RST)的绝对口服生物利用度较低,仅为20%,且仅有10%以代谢物N-去甲罗伐他汀的形式被回收。由于它是一种亲水性他汀类药物,因此 RST 依靠有机阴离子转运多肽-1B1(OATP-1B1)作为进入肝细胞主动转运的关键机制。槲皮素(QUE)是一种生物增强剂和 OATP1B1 抑制剂,可提高 RST 的生物利用度和药代动力学:本研究包括开发一种简单、有效的生物分析反相高效液相色谱法(RP-HPLC)来估算 RST,并研究同时服用生物增强剂 QUE 对其生物利用度的影响:色谱分离采用 Kromasil 100 C18(250 mm × 4.6 mm,5 μm)分析柱,流动相为乙腈(ACN):用冰醋酸(55:45 Vol.%)调节 pH 值的醋酸缓冲液(ACN),流速为 1.0 ml/min,监测波长为 242 nm。萃取的最终溶剂为乙腈-甲醇(体积比为 50:50)。所开发的方法被成功地应用于大鼠联合给药 QUE 后 RST 的药代动力学研究,该研究采用非室分析法估算药物的血药浓度:结果:发现当大鼠在 120 分钟(tmax)与 QUE 同时给药时,RST 的药代动力学发生了显著变化(血液中 RST 的最高浓度(Cmax)= 67.3 ng/ml 至 122.2 ng/ml)(p < 0.001)、曲线下面积(AUC)0-t(p < 0.0001)和 AUC0-inf(p = 0.0005):结果与 QUE 通过草药-药物相互作用提高大鼠血浆水平的事实相符。
{"title":"Evaluation of Quercetin's Bioenhancing Effect on Oral Pharmacokinetics of Rosuvastatin in Wistar Rats Using RP-HPLC Method.","authors":"Rachana S Bhimanwar, Lata P Kothapalli, Akshay Khawshi","doi":"10.2174/0118715257258735231016112348","DOIUrl":"https://doi.org/10.2174/0118715257258735231016112348","url":null,"abstract":"<p><strong>Background: </strong>The absolute oral bioavailability of rosuvastatin (RST), a secondgeneration statin, is low i.e. 20% and only 10% is recovered as metabolite N-desmethy l rosuvistatin. Since it is a hydrophilic statin, RST relies on the organic anion transporting polypeptide- 1B1 (OATP-1B1), as the key mechanism for active transport into hepatocytes. Quercetin (QUE) being a bio enhancer and inhibitor of OATP1B1 can augment the bioavailability and pharmacokinetics of RST.</p><p><strong>Objectives: </strong>The present study includes the development of a simple and validated bioanalytical Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the estimation of RST and to study the effect of co-administration of QUE as a bio enhancer on its bioavailability.</p><p><strong>Methods: </strong>An analytical column of Kromasil 100, C18 (250 mm × 4.6 mm, 5 μm), was used for chromatographic separationand acetonitrile (ACN): acetic acid buffer pH 3.0 adjusted with glacial acetic acid (55:45 Vol. %) as mobile phase with flow rate 1.0 ml/min monitored at 242 nm. The ACN: methanol (50:50 Vol. %) was employed as the final solvent for extraction. The developed method has been successfully applied in a study on the pharmacokinetics of the drug RST in rats after co-administration of QUE, which was carried out using non-compartmental analysis in order to estimate the blood concentration of the drug.</p><p><strong>Results: </strong>The pharmacokinetics of RST was found to be altered significantly (highest concentration of RST in the blood (<i>C</i><sub>max</sub>) = 67.3 ng/ml to 122.2 ng/ml) (p < 0.001), area under curve (AUC)<sub>0-t</sub> (p < 0.0001) and AUC<sub>0-inf</sub> (p = 0.0005) when co-administered with QUE at 120 min (<i>t</i><sub>max</sub>).</p><p><strong>Conclusion: </strong>The results are in accordance with the fact that QUE increases plasma levels in rats through herb-drug interactions.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":"22 4","pages":"456-465"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herbal Medicine- A Friend or a Foe of Cardiovascular Disease. 草药-心血管疾病的朋友或敌人。
Pub Date : 2024-01-01 DOI: 10.2174/0118715257251638230921045029
Harmanjit Kaur, Samneet Singh, Sai G Kanagala, Vasu Gupta, Meet A Patel, Rohit Jain

Background: Herbal remedies are used by 80% of the Asian population in primary health care as per WHO. According to current research, the herbal medicine market was valued at nearly USD 166 billion in 2021 and is expected to reach approximately USD 348 billion by 2028. Increased incidence of chronic conditions such as diabetes, asthma, coronary artery disease, osteoarthritis, has fueled the growing interest in traditional herbal and plant-derived treatments among researchers. In addition, rural communities in developing nations have renewed interest in herbal treatments due to lower cost and easy availability.

Objectives: Aim of the paper is to highlight the role of five of more commonly used herbal medicines that are Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza in cardiovascular disorders.

Methods: A PubMed search was done using the keywords Herbal Medicine, Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza. Articles which were available for free access were utilized. No formula inclusion or exclusion criteria was followed. A total of 42 papers were included for the study.

Conclusion: Although there have been encouraging outcomes with the use of these herbal medications, many of these products are poorly monitored and are yet to be studied in detail regarding their adverse effects. Moreover, these medicinal products are known to interact with various drugs. To compete with the expanding pharmaceutical industry, more medicinally helpful herbal items must be used and scientifically validated.

背景:根据世界卫生组织,80%的亚洲人口在初级卫生保健中使用草药。根据目前的研究,2021年草药市场价值近1660亿美元,预计到2028年将达到约3480亿美元。糖尿病、哮喘、冠状动脉疾病、骨关节炎等慢性病发病率的增加,激发了研究人员对传统草药和植物衍生治疗的兴趣。此外,由于成本较低且易于获得,发展中国家的农村社区重新对草药治疗产生了兴趣。目的:本文的目的是强调银杏、大蒜、亚麻籽、人参、丹参五种常用草药在心血管疾病中的作用。方法:检索PubMed,关键词为草药、银杏、大蒜、亚麻籽、人参、丹参。利用了可免费获取的物品。未遵循配方奶粉纳入或排除标准。这项研究共收录了42篇论文。结论:尽管使用这些草药取得了令人鼓舞的结果,但其中许多产品的监测不力,尚待详细研究其不良反应。此外,已知这些医药产品与各种药物相互作用。为了与不断扩大的制药行业竞争,必须使用更具药用价值的草药并进行科学验证。
{"title":"Herbal Medicine- A Friend or a Foe of Cardiovascular Disease.","authors":"Harmanjit Kaur, Samneet Singh, Sai G Kanagala, Vasu Gupta, Meet A Patel, Rohit Jain","doi":"10.2174/0118715257251638230921045029","DOIUrl":"10.2174/0118715257251638230921045029","url":null,"abstract":"<p><strong>Background: </strong>Herbal remedies are used by 80% of the Asian population in primary health care as per WHO. According to current research, the herbal medicine market was valued at nearly USD 166 billion in 2021 and is expected to reach approximately USD 348 billion by 2028. Increased incidence of chronic conditions such as diabetes, asthma, coronary artery disease, osteoarthritis, has fueled the growing interest in traditional herbal and plant-derived treatments among researchers. In addition, rural communities in developing nations have renewed interest in herbal treatments due to lower cost and easy availability.</p><p><strong>Objectives: </strong>Aim of the paper is to highlight the role of five of more commonly used herbal medicines that are Ginkgo biloba, Garlic, Flaxseed, Ginseng, <i>Salvia miltiorrhiza</i> in cardiovascular disorders.</p><p><strong>Methods: </strong>A PubMed search was done using the keywords Herbal Medicine, Ginkgo biloba, Garlic, Flaxseed, Ginseng, <i>Salvia miltiorrhiza</i>. Articles which were available for free access were utilized. No formula inclusion or exclusion criteria was followed. A total of 42 papers were included for the study.</p><p><strong>Conclusion: </strong>Although there have been encouraging outcomes with the use of these herbal medications, many of these products are poorly monitored and are yet to be studied in detail regarding their adverse effects. Moreover, these medicinal products are known to interact with various drugs. To compete with the expanding pharmaceutical industry, more medicinally helpful herbal items must be used and scientifically validated.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"101-105"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between waist circumference and magnesium and uric acid in indigenous Argentinean children living at high altitude. 生活在高海拔地区的阿根廷土著儿童腰围与镁和尿酸之间的关系。
Valeria Hirschler, M Esteban, C González, C Molinari, L Castano

Background: Studies in adults show that central obesity increases the likelihood of Type 2 diabetes (T2DM).

Objective: To determine the association between waist circumference (WC) and non-traditional risk factors such as magnesium (Mg), phosphorus, and uric acid in indigenous children living at high altitudes.

Methods: A total of 354 (166 M) indigenous school children, aged 9.6 + 2.3 years, were enrolled in a cross-sectional study in November 2011. Central obesity was defined as WC > 90th percentile according to age and sex. Low Mg and phosphorus levels were defined as serum Mg <1.8 mg/dL and phosphorus <2.4 mg/dL . Hyperuricemia was defined as serum uric acid > 7 mg/dL.

Results: The prevalence of central obesity was 6.8% (24/354). None of the children had hyperuricemia or low P levels. HypoMg was identified in 21.7% (57/263). There was a significant association between WC (z-score) and Mg (r-015), uric acid (r0.28), phosphorus (r-0.30), HOMA-IR (r0.49), Triglycerides (r0.24), and HDL-C (r0.24). However, calcium, sodium, and potassium were not significantly associated with WC. As z-WC quartiles increased Mg and phosphorus levels significantly decreased, whereas uric acid levels increased. Multiple linear regression analysis showed that z-WC was associated significantly and directly with uric acid (B0.31), triglycerides (B0.004), and HOMA-IR (B0.35); and inversely with Mg (B-0.83) and phosphorus (B-0.25), adjusted for confounding variables (R2 0.34).

Conclusion: Our results indicate that central obesity was significantly and inversely associated with Mg and phosphorus and directly with uric acid in indigenous school children. Supplementation with Mg and/or phosphorus could prevent future cardiovascular disease. Prospective and randomized studies should be performed to confirm these findings.

背景:成人研究表明,中心性肥胖会增加 2 型糖尿病(T2DM)的发病率:成人研究表明,中心性肥胖会增加罹患 2 型糖尿病(T2DM)的可能性:目的:确定生活在高海拔地区的土著儿童腰围(WC)与镁(Mg)、磷和尿酸等非传统风险因素之间的关系:2011 年 11 月,一项横断面研究共招募了 354 名(166 名男童)年龄为 9.6 + 2.3 岁的原住民学童。根据年龄和性别,中心性肥胖的定义为腹围大于 90 百分位数。镁和磷水平低的定义是血清镁为 1.8 毫克/分升,磷为 2.4 毫克/分升。高尿酸血症是指血清尿酸为 7 毫克/分升:中心性肥胖率为 6.8%(24/354)。没有一名儿童患有高尿酸血症或P水平过低。21.7%的儿童(57/263)患有低镁血症。腹围(z-score)与镁(r-015)、尿酸(r0.28)、磷(r-0.30)、HOMA-IR(r0.49)、甘油三酯(r0.24)和高密度脂蛋白胆固醇(r0.24)之间存在明显关联。然而,钙、钠和钾与 WC 没有明显关联。随着 z-WC 四分位数的增加,镁和磷的水平明显下降,而尿酸的水平则有所上升。多元线性回归分析表明,经混杂变量调整后,z-WC与尿酸(B0.31)、甘油三酯(B0.004)和HOMA-IR(B0.35)显著直接相关;与镁(B-0.83)和磷(B-0.25)成反比(R2 0.34):我们的研究结果表明,原住民学龄儿童的中心性肥胖与镁和磷显著成反比,与尿酸直接相关。补充镁和/或磷可预防未来的心血管疾病。应进行前瞻性随机研究来证实这些发现。
{"title":"Association between waist circumference and magnesium and uric acid in indigenous Argentinean children living at high altitude.","authors":"Valeria Hirschler, M Esteban, C González, C Molinari, L Castano","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Studies in adults show that central obesity increases the likelihood of Type 2 diabetes (T2DM).</p><p><strong>Objective: </strong>To determine the association between waist circumference (WC) and non-traditional risk factors such as magnesium (Mg), phosphorus, and uric acid in indigenous children living at high altitudes.</p><p><strong>Methods: </strong>A total of 354 (166 M) indigenous school children, aged 9.6 + 2.3 years, were enrolled in a cross-sectional study in November 2011. Central obesity was defined as WC &gt; 90th percentile according to age and sex. Low Mg and phosphorus levels were defined as serum Mg &lt;1.8 mg/dL and phosphorus &lt;2.4 mg/dL . Hyperuricemia was defined as serum uric acid &gt; 7 mg/dL.</p><p><strong>Results: </strong>The prevalence of central obesity was 6.8% (24/354). None of the children had hyperuricemia or low P levels. HypoMg was identified in 21.7% (57/263). There was a significant association between WC (z-score) and Mg (r-015), uric acid (r0.28), phosphorus (r-0.30), HOMA-IR (r0.49), Triglycerides (r0.24), and HDL-C (r0.24). However, calcium, sodium, and potassium were not significantly associated with WC. As z-WC quartiles increased Mg and phosphorus levels significantly decreased, whereas uric acid levels increased. Multiple linear regression analysis showed that z-WC was associated significantly and directly with uric acid (B0.31), triglycerides (B0.004), and HOMA-IR (B0.35); and inversely with Mg (B-0.83) and phosphorus (B-0.25), adjusted for confounding variables (R2 0.34).</p><p><strong>Conclusion: </strong>Our results indicate that central obesity was significantly and inversely associated with Mg and phosphorus and directly with uric acid in indigenous school children. Supplementation with Mg and/or phosphorus could prevent future cardiovascular disease. Prospective and randomized studies should be performed to confirm these findings.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"None"},"PeriodicalIF":0.0,"publicationDate":"2016-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological evidence of α-adrenergic receptors in the hypotensive effect of Chamaemulum nobile L. 金钗茶降血压作用中α肾上腺素能受体的药理证据
M Hebi, M Ajebli, N A Zeggwagh, M Eddouks

This study aims to evaluate the underlying mechanism of action involved in the hypotensive effect of Chamaemulum nobile L. (Cn) aqueous extract and in anesthetized Wistar rats. Lyophilized aqueous extract was administered in the jugular vein, arterial blood pressure and heart rate were measured in the carotide artery over 120 min of injection throughout an invasive direct blood pressure measuring procedure. Intravenous bolus injection of aqueous Cn extract at the doses of 50, 100 and 200 mg/kg produced a dose dependent reduction in arterial blood pressure and heart rate (p<0.001). Specific receptor antagonists (Phentolamine, Terazosin and Atropine) and pharmacological agents (N(omega)-Nitro-L-Arginine Methyl Ester and Captopril) were used for determining the underlying mechanism involved in the hypotensive effect of Cn. Only Phentolamine treatment (2 mg/kg) reduced significantly the hypotensive effect of aqueous Cn extract at a dose of 200 mg/kg. Intravenous perfusion of aqueous Cn extract caused a significant reduction of arterial blood pressure (p<0.01) and reduced the hypertensive effect of intravenous injection of norepinephrine at a dose of 1 µg/kg. We conclude that aqueous Cn extract exhibits a hypotensive effect which may be probably due to an alpha adrenergic receptor blockade mechanism.

本研究旨在评估金钗茶(Cn)水提取物和麻醉 Wistar 大鼠降压作用的基本作用机制。在颈静脉注射冻干水提取物,在注射后 120 分钟内通过有创直接血压测量程序在颈动脉测量动脉血压和心率。静脉注射 50、100 和 200 毫克/千克剂量的 Cn 水提取物,动脉血压和心率的降低与剂量有关(p<0.05)。
{"title":"Pharmacological evidence of α-adrenergic receptors in the hypotensive effect of Chamaemulum nobile L.","authors":"M Hebi, M Ajebli, N A Zeggwagh, M Eddouks","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study aims to evaluate the underlying mechanism of action involved in the hypotensive effect of Chamaemulum nobile L. (Cn) aqueous extract and in anesthetized Wistar rats. Lyophilized aqueous extract was administered in the jugular vein, arterial blood pressure and heart rate were measured in the carotide artery over 120 min of injection throughout an invasive direct blood pressure measuring procedure. Intravenous bolus injection of aqueous Cn extract at the doses of 50, 100 and 200 mg/kg produced a dose dependent reduction in arterial blood pressure and heart rate (p<0.001). Specific receptor antagonists (Phentolamine, Terazosin and Atropine) and pharmacological agents (N(omega)-Nitro-L-Arginine Methyl Ester and Captopril) were used for determining the underlying mechanism involved in the hypotensive effect of Cn. Only Phentolamine treatment (2 mg/kg) reduced significantly the hypotensive effect of aqueous Cn extract at a dose of 200 mg/kg. Intravenous perfusion of aqueous Cn extract caused a significant reduction of arterial blood pressure (p<0.01) and reduced the hypertensive effect of intravenous injection of norepinephrine at a dose of 1 &#181;g/kg. We conclude that aqueous Cn extract exhibits a hypotensive effect which may be probably due to an alpha adrenergic receptor blockade mechanism.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"None"},"PeriodicalIF":0.0,"publicationDate":"2016-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Insights on the Impact of Statin Therapy in the Susceptibility to Hypovitaminosis D Through Serum Lipidome Profiling. 通过血清脂质体图谱分析,了解他汀类药物治疗对维生素 D 缺乏症易感性的影响。
Ana Rita Santos Estrela, Frederico Cerveira, Bárbara Regadas Correia, Ana Reis, Margarida Fardilha, Pedro Domingues, Rita Ferreira, M Rosário M Domingues

Hypovitaminosis D is a worldwide clinical problem, affecting populations in numerous ways. Several factors seem to affect vitamin D metabolism, including the suggestion that therapy with the lipid lowering HMG-CoA inhibitors might modulate vitamin D levels. However, the relationship between statins intake and serum levels of vitamin D is still controversial. The present work aimed to add new insights on the association between statins therapy, and more specifically the generation of statins, and the lipid profile in a population of 106 subjects treated with these HMG-CoA inhibitors. Data showed that despite a higher prevalence of hipovitaminosis D in subjects treated with statins, there is no association between statin generation, total and LDL cholesterol and vitamin D levels. Moreover, second generation statins, the most common treatment of hypercholesterolemia in the studied population, promoted the remodelling of serum fatty acids that was characterized by the increase of arachidonic acid (AA) relative levels without affecting eicosapentaenoic acid (EPA) levels. Among statin treated subjects, vitamin D levels did not affect serum fatty acid profile. The statin-related increased ratio AA/EPA suggests a pro- inflammatory status, whose long-term impact should be better clarified in the future.

维生素 D 不足是一个世界性的临床问题,以多种方式影响着人群。影响维生素 D 代谢的因素似乎有很多,其中包括降血脂药物 HMG-CoA 抑制剂可能会调节维生素 D 水平。然而,他汀类药物摄入量与血清维生素 D 水平之间的关系仍存在争议。本研究旨在为他汀类药物治疗(更具体地说是他汀类药物的产生)与使用这些 HMG-CoA 抑制剂的 106 名受试者的血脂状况之间的关系提供新的见解。数据显示,尽管他汀类药物治疗受试者髋部维生素 D 的患病率较高,但他汀类药物的产生、总胆固醇和低密度脂蛋白胆固醇与维生素 D 水平之间并无关联。此外,第二代他汀类药物是研究人群中最常见的治疗高胆固醇血症的药物,它促进了血清脂肪酸的重塑,其特点是花生四烯酸(AA)相对水平增加,而不影响二十碳五烯酸(EPA)水平。在接受他汀类药物治疗的受试者中,维生素 D 水平不会影响血清脂肪酸谱。与他汀类药物相关的 AA/EPA 比率升高表明,他汀类药物会促进炎症状态,其长期影响应在未来得到更好的阐明。
{"title":"New Insights on the Impact of Statin Therapy in the Susceptibility to Hypovitaminosis D Through Serum Lipidome Profiling.","authors":"Ana Rita Santos Estrela, Frederico Cerveira, Bárbara Regadas Correia, Ana Reis, Margarida Fardilha, Pedro Domingues, Rita Ferreira, M Rosário M Domingues","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hypovitaminosis D is a worldwide clinical problem, affecting populations in numerous ways. Several factors seem to affect vitamin D metabolism, including the suggestion that therapy with the lipid lowering HMG-CoA inhibitors might modulate vitamin D levels. However, the relationship between statins intake and serum levels of vitamin D is still controversial. The present work aimed to add new insights on the association between statins therapy, and more specifically the generation of statins, and the lipid profile in a population of 106 subjects treated with these HMG-CoA inhibitors. Data showed that despite a higher prevalence of hipovitaminosis D in subjects treated with statins, there is no association between statin generation, total and LDL cholesterol and vitamin D levels. Moreover, second generation statins, the most common treatment of hypercholesterolemia in the studied population, promoted the remodelling of serum fatty acids that was characterized by the increase of arachidonic acid (AA) relative levels without affecting eicosapentaenoic acid (EPA) levels. Among statin treated subjects, vitamin D levels did not affect serum fatty acid profile. The statin-related increased ratio AA/EPA suggests a pro- inflammatory status, whose long-term impact should be better clarified in the future.</p>","PeriodicalId":93924,"journal":{"name":"Cardiovascular & hematological agents in medicinal chemistry","volume":" ","pages":"None"},"PeriodicalIF":0.0,"publicationDate":"2016-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular & hematological agents in medicinal chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1